Fey, M. F.

Fey, M. F. (2011). VI. DNA microarray technology. Principles and application to the analysis of malignant tumours (with special emphasis on lymphoma). Annals of oncology, 22(Suppl. 4), iv44-iv46. Oxford University Press 10.1093/annonc/mdr172

Fey, M. F.; Greil, R.; Jost, L. M. (2005). ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients. Annals of oncology, 16(suppl_1), i48-i49. Oxford University Press 10.1093/annonc/mdi802

Fey, M. F. (2005). Principles of Molecular Oncology. Annals of oncology, 16(1), pp. 175-176. Oxford University Press 10.1093/annonc/mdi011

Fey, M. F. (2003). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of acute myeloblastic leukaemia (AML) in adult patients. Annals of oncology, 14(8), pp. 1161-1162. Oxford University Press 10.1093/annonc/mdg337

Von Rohr, A.; Schmitz, S.-F. H.; Tichelli, A.; Hess, U.; Piguet, D.; Wernli, M.; Frickhofen, N.; Konwalinka, G.; Zulian, G.; Ghielmini, M.; Rufener, B.; Racine, C.; Fey, M. F.; Cerny, T.; Betticher, D.; Tobler, A. (2002). Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. Annals of oncology, 13(10), pp. 1641-1649. Oxford University Press 10.1093/annonc/mdf272

Fey, M. F. (2002). The impact of chip technology on cancer medicine. Annals of oncology, 13(suppl 4), pp. 109-113. Oxford University Press 10.1093/annonc/mdf647

Tschan, Mario; Peters, U. R.; Cajot, J. F.; Betticher, D. C.; Fey, M. F.; Tobler, A. (1999). The cyclin-dependent kinase inhibitors p18INK4c and p19INK4d are highly expressed in CD34+ progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells. British journal of haematology, 106(3), pp. 644-651. Wiley-Blackwell 10.1046/j.1365-2141.1999.01617.x

Zahnd, D.; Aebi, S.; Rusterholz, S.; Fey, M. F.; Borner, M. M. (1999). A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices. Annals of oncology, 10(6), pp. 727-729. Oxford University Press 10.1023/A:1008334313918

Betticher, D. C.; Ratschiller, D.; Hsu Schmitz, S.-F.; Von Rohr, A.; Hess, U.; Zulian, G.; Wernli, M.; Tichelli, A.; Tobler, A.; Fey, M. F.; Cerny, T. (1998). Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Annals of oncology, 9(7), pp. 721-726. Oxford University Press 10.1023/A:1008273131598

Borner, M. M.; Castiglione, M.; Bacchi, M.; Weber, Walter; Herrmann, R.; Fey, M. F.; Pagani, O.; Leyvraz, S.; Morant, R.; Pestalozzi, B.; Hanselmann, S.; Goldhirsch, A. (1998). The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial. Annals of oncology, 9(5), pp. 535-541. Oxford University Press 10.1023/A:1008270916325

Goldhirsch, A.; Gelber, R. D.; Castiglione, M.; O'Neill, A.; Thürlimann, B.; Rudenstam, C.-M; Lindtner, J.; Collins, J.; Forbes, J.; Crivellari, D.; Coates, A.; Cavalli, F.; Simoncini, E.; Fey, M. F.; Pagani, O.; Price, K.; Senn, H.-J. (1997). Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: Results of the International Breast Cancer Study Group (IBCSG) Trial VI. Annals of oncology, 8(8), pp. 751-756. Oxford University Press 10.1023/A:1008220301866

Fey, M. F.; Tobler, Andreas (1996). Tumour heterogeneity and clonality - an old theme revisited. Annals of oncology, 7(2), pp. 121-128. Oxford University Press 10.1093/oxfordjournals.annonc.a010537

Seitz, M.; Loetscher, P.; Fey, M. F.; Tobler, Andreas (1994). CONSTITUTIVE mRNA AND PROTEIN PRODUCTION OF MACROPHAGE COLONY-STIMULATING FACTOR BUT NOT OF OTHER CYTOKINES BY SYNOVIAL FIBROBLASTS FROM RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS. Rheumatology, 33(7), pp. 613-619. Oxford University Press 10.1093/rheumatology/33.7.613